Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. medicsen

MedicSen

A new innovative method for diabetes treatment, the artificial pancreas system

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 MedicSen project word cloud

Explore the words cloud of the MedicSen project. It provides you a very rough idea of what is the project "MedicSen" about.

treatment    first    size    cardiovascular    company    pressure    personalize    methodology    accomplishment    commercial    dimension    mind    patient    market    sensors    obesity    diabetes    socio    individual    spending    disease    release    health    economic    there    responsible    monitoring    structure    temperature    daily    glucose    usual    telemonitoring    individuals    therapies    diseases    telemedicine    medicsen    chronic    environment    reduce    heart    apps    union    adjusting    employees    poor    blood    service    ing    examples    free    dispenser    put    prove    intention    technological    calculations    movement    modifying    curve    performed    dose    needle    context    personalized    adapting    2017    drug    transformation    continuous    102m    patented    burden    innovative    7m    worldwide    keeping    ebitda    interaction    facts    reducing    moment    rate    healthcare   

Project "MedicSen" data sheet

The following table provides information about the project.

Coordinator		 MEDICSENSORS SL 

Organization address
address: CALLE NUNEZ DE BALBOA, NUM. 35 PLANTA 6
city: MADRID
postcode: 28001
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Spain [ES]
 Project website http://www.medicsen.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-08-01   to  2018-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MEDICSENSORS SL ES (MADRID) coordinator 50˙000.00

Map

 Project objective

There is a very well-known worldwide problem in the management of chronic diseases and high costs associated to its control resulting in a poor service. Different studies prove how m-health (telemonitoring, apps and sensors) facilitate better understanding and management of the disease. Diabetes is one of the major examples of these facts.

MEDICSEN has patented an innovative methodology to personalize the management of chronic diseases that will reduce its socio-economic impact. MEDICSEN is based on continuous monitoring, daily friendly interaction with the patient, and personalized therapies through needle-free drug dispenser.

MEDICSEN aim to promote the necessary change in the structure of treatment of chronic diseases, leading the transformation movement towards personalized telemedicine and therefore improving control and reducing spending on such common diseases as cardiovascular, diabetes or obesity. The first case study of technological and commercial application for this general system environment is performed for diabetes but keeping the intention of adapting it to other chronic diseases in the future. Then, MEDICSEN is responsible for modifying the patient glucose curve analysis according to his/her usual behaviour and the value of various parameters (such as temperature, blood pressure or heart rate), thus adjusting the treatment specifically for each individual context and for each moment so the patient can release his/her mind from the dose calculations.

The project has a relevant European Dimension. Chronic diseases represent a significant burden on individuals and healthcare systems in the European Union and beyond. The accomplishment of the objectives will result in an EBITDA of 102M€ in five years after put into market MEDICSEN (from € 0.7M in 2017) and an increase of the company size (from 7 to 100 employees).

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MEDICSEN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MEDICSEN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

ImmuneHunter (2017)

Bioinformatics platform for profiling of health: allowing early and accurate detection of multiple diseases simultaneously

Read More  

SensUS (2018)

SensUS: A non-invasive and quantitative ultrasound (QUS) device for an objective monitoring of the childbirth labour process.

Read More